An observational study in Stroke, sponsored by Adi Negev-Nahalat Eran. Recruiting at 1 site in Israel. Open to participants aged 18 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-10-03.
Sponsored by Adi Negev-Nahalat Eran · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 127 studies in Stroke with a site in Israel — 12 open to participants now, 21 under way, 3 of them phase 3. Stroke · Israel.
Among the 127 studies in Stroke with a site in Israel, this one is the 26th largest by planned enrollment of the 36 observational ones that give a count, is one of 4 that started in 2024, is one of 38 observational ones, reaches primary completion later than 10 of the 20 other live ones, and was the 118th registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →12 of the 127 studies in Stroke with a site in Israel are open now. Recruiting first, the newest first:
Motion Informatics LTD · Sites in Israel
Ages 18+
Eli Lilly and Company · Sites in Israel, Argentina, Australia and 35 more countries
Ages 50+
Adi Negev-Nahalat Eran · Sites in Israel
Ages 18+
Adi Negev-Nahalat Eran · Sites in Israel, Palestinian Territories
Ages 18–85 · Healthy volunteers
Assaf-Harofeh Medical Center · Sites in Israel
Ages 50–85
A study can be open while its sites in Israel have not opened yet or have stopped. Only those recruiting at a site in Israel →
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 18 Years to 85 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
127 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 5 · Phase 2 14 · Phase 3 24 · Phase 4 2
First in 2000; this study’s year is marked. 4 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is below the median of 150 across 1,971 observational studies indexed under Stroke.
Median enrollment 72 across the 86 interventional studies, 196 across the 36 observational. Of the 69 that completed or were terminated, 21 (30%) have results posted.
This tab as a report to print or save as PDF → With an account.
44 of 127 have an industry lead sponsor. The 10 most frequent:
Adi Negev-Nahalat Eran is the lead sponsor of 4 studies on the registry; 4 are open to participants now.
Adi Negev-Nahalat Eran has 3 studies filed under Stroke — fewer than ten, so there is no comparison to draw.
5 of the studies in Stroke with a site in Israel that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07404761Motion Informatics LTDSafety and Effectiveness of Spatial StimelMD (SSMD) in Subjects With Upper Limb Neuromotor Impairments | 2026-12-30 |
| NCT06441552Adi Negev-Nahalat EranThe Natural History of Recovery After Stroke | 2027-01 |
| NCT06497881Adi Negev-Nahalat EranUpper Limb Movement Quality Following Stroke | 2027-01-01 |
| NCT07056049Adi Negev-Nahalat EranThe Efficacy of Additional Motor Training Dosage During the Early Stages Post Stroke on the Upper Extremity Recovery | 2027-01-15 |
| NCT06096831University of HaifaLiving With Stroke - Sustainable Utilization of Healthcare Services | 2027-03 |
Add all 5 to your calendar (.ics) → With an account.
Among the 127 studies in Stroke with a site in Israel, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The aim of this study is to monitor the daily upper limb movement of persons with stroke, and to relate these quantities to measures of recovery and impairment.
This study is part of The Natural History of Stroke Recovery project. In this study the investigators plan to develop, test and validate an algorithm and software for using Inertial Measuring Units (IMUs) to monitor upper limb daily movement. Then, investigators plan to use this system to monitor such activity in stroke patients.
Investigators also plan to develop, test and validate an algorithm and software to test proprioception acuity based on muscle synergy during active and passive movement. Muscle synergy will be determined based on muscles' electrical activity, as measured using surface electromyography (EMG).
Investigators will then test the relation between daily movements of the upper limb in stroke patients, and their recovery/impairment levels, including proprioception acuity.
Persons with stroke and healthy adults.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Persons after a stroke. See inclusion/exclusion.
Healthy persons. See inclusion/exclusion.
Hand movements-count
The number of hand movements (count)
Time frame: One or two occasions over 1-6 hours each.
Hand movements-duration
The total and average (per hour) time the hands moved, over the tested period. Measured in minutes.
Time frame: One or two occasions over 1-6 hours each.
Active joint range
Maximum, minimum, and mean range of motion of the joints during daily activity. Measured in degrees/radians.
Time frame: One or two occasions over 1-6 hours each.
Wrist distance
The maximum, average and total distance of the wrist from the body during movements. Measured in cm.
Time frame: One or two occasions over 1-6 hours each.
Fugl-Meyer Assessment (FMA)
Fugl-Meyer Assessment: Motor score of the upper limb is on a 0-66 scale. High score is better.
Time frame: One occasions during the first month following recruitment.
Action Research Arm Test (ARAT)
Action Research Arm Test Score is on a 0-57 scale. High score is better.
Time frame: One occasions during the first month following recruitment.
Proprioception-1
The difference between joint angles in an angle matching task. E.g., matching the shoulder angle of a passively moved arm with the contralateral arm. Angles include both anatomical angles and elevation angles. Measured in degrees/radians.
Time frame: One occasions during the first month following recruitment.
Proprioception-2
Parameters of the correlation (regression) between EMG signals during active and passive movement. Including the constant (in mV), slope (arbitrary units) and R\^2 (arbitrary units).
Time frame: One occasions during the first month following recruitment.
Proprioception-3
Delay between hand movement initiation observed kinematical (acceleration) and kinetically (EMG signal). Measured in msec.
Time frame: One occasions during the first month following recruitment.
Joint range of motion
Maximum and minimum joints range of motion (active and passive). Measured in degrees/radians.
Time frame: One or two occasions over 1-6 hours each.
Synergies
Parameters of the correlation (regression) between the kinematic signals of the different upper extremity segments. Including the slope (arbitrary units) and R\^2 (arbitrary units).
Time frame: One or two occasions over 1-6 hours each.
Angular velocity.
Maximum and average angular velocity of the joints during daily activity. Measured in degrees/radians per second
Time frame: One or two occasions over 1-6 hours each.
Movement volume
Volume occupied by the limb segments calculated using the 3D location of the joints. Measured in cm\^3.
Time frame: One or two occasions over 1-6 hours each.
Whole body movement time
The total and average (per hour) time of movements of the whole body. Measured in minutes.
Time frame: One or two occasions over 1-6 hours each.
Plan to share: Yes — All IPD that underlie results in a publication.
Supporting information: Study protocol, Statistical analysis plan, Clinical study report, Analytic code
Time frame: Will be available with publication of results, indefinitely.
Access criteria: Open access.
No publications or documents are linked to this record.
Started Jul 2024 (actual). Primary completion is estimated for Jan 2027, 29 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Adi Negev-Nahalat Eran